tradingkey.logo

Work Medical Technology Group Ltd

WOK
1.380USD
+0.130+10.40%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
2.01KMarktkapitalisierung
--KGV TTM

Work Medical Technology Group Ltd

1.380
+0.130+10.40%

mehr Informationen über Work Medical Technology Group Ltd Unternehmen

Work Medical Technology Group Ltd is a holding company mainly engaged in the manufacturing of medical devices. The Company's main products include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, and other Class I disposable medical devices, disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, anesthesia masks, laryngoscope blades, yankauer suction sets, nasal oxygen cannulas, and other Class II disposable medical devices, KN95 masks, filtering half mask, and other medical devices, as well as medical innovative devices and equipment, such as visualized prostatic dilatation catheter. The Company principally conducts its businesses in domestic and overseas markets, such as Asia, Africa, Europe, North America, South America, and Oceania.

Work Medical Technology Group Ltd Informationen

BörsenkürzelWOK
Name des UnternehmensWork Medical Technology Group Ltd
IPO-datumAug 23, 2024
CEOWu (Shuang)
Anzahl der mitarbeiter229
WertpapierartOrdinary Share
GeschäftsjahresendeAug 23
AddresseBuilding 23, No. 2 Tonghuinan Rd., Xiaoshan District
StadtHANGZHOU
BörseNASDAQ OMX - NASDAQ BASIC
LandChina
Postleitzahl311200
Telefon8657182613568
Websitehttps://www.workmedtech.com/
BörsenkürzelWOK
IPO-datumAug 23, 2024
CEOWu (Shuang)

Führungskräfte von Work Medical Technology Group Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Shuang Wu
Mr. Shuang Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ningfang Liang
Mr. Ningfang Liang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Baiming Yu
Mr. Baiming Yu
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Xiaoyang Li
Mr. Xiaoyang Li
Independent Director
Independent Director
--
--
Mr. Zhongxuan Li
Mr. Zhongxuan Li
Independent Director
Independent Director
--
--
Mr. Robert Johnson
Mr. Robert Johnson
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Shuang Wu
Mr. Shuang Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ningfang Liang
Mr. Ningfang Liang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Baiming Yu
Mr. Baiming Yu
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Xiaoyang Li
Mr. Xiaoyang Li
Independent Director
Independent Director
--
--
Mr. Zhongxuan Li
Mr. Zhongxuan Li
Independent Director
Independent Director
--
--
Mr. Robert Johnson
Mr. Robert Johnson
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2023
FY2022
FY2021
FY2020
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Others
13.72M
0.00%
Medical devices other than masks
8.00M
58.95%
Marks
5.09M
37.53%
Commodity trading
325.43K
2.40%
Nach RegionUSD
Name
Umsatz
Anteil
China
12.60M
92.87%
Overseas market
967.69K
7.13%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Others
13.72M
0.00%
Medical devices other than masks
8.00M
58.95%
Marks
5.09M
37.53%
Commodity trading
325.43K
2.40%

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
UBS Financial Services, Inc.
0.15%
LWY GROUP LTD
0.04%
Sabby Management, LLC
0.02%
North Star Investment Management Corporation
0.01%
Andere
99.78%
Aktionäre
Aktionäre
Anteil
UBS Financial Services, Inc.
0.15%
LWY GROUP LTD
0.04%
Sabby Management, LLC
0.02%
North Star Investment Management Corporation
0.01%
Andere
99.78%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
0.15%
Corporation
0.04%
Investment Advisor/Hedge Fund
0.03%
Andere
99.78%

Institutionelle Beteiligung

Aktualisiert: Wed, Jan 21
Aktualisiert: Wed, Jan 21
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q4
12
333.00
0.07%
--
2025Q4
13
2.97K
0.18%
+2.17K
2025Q3
9
79.91K
8.32%
+78.09K
2025Q2
8
6.35M
12.98%
-18.36K
2025Q1
8
6.35M
37.37%
-18.36K
2024Q4
14
12.62M
86.49%
+6.36M
2024Q3
10
12.51M
85.72%
+12.51M

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
UBS Financial Services, Inc.
--
0%
-5.00
-100.00%
Sep 30, 2025
LWY GROUP LTD
625.00
0.05%
--
--
Feb 14, 2025
Sabby Management, LLC
272.00
0.02%
+272.00
--
Sep 30, 2025
Virtu Americas LLC
31.00
0%
+31.00
--
Sep 30, 2025
Desjardins Securities Inc.
20.00
0%
+20.00
--
Sep 30, 2025
Two Sigma Investments, LP
5.00
0%
+5.00
--
Sep 30, 2025
XTX Markets LLC
4.00
0%
+4.00
--
Sep 30, 2025
Citadel Advisors LLC
1.00
0%
-2.00
-66.67%
Sep 30, 2025
HRT Financial LP
--
0%
-2.00
-100.00%
Mar 31, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Dec 24, 2025
Merger
100→1
Oct 17, 2025
Merger
100→1
Datum
Ex-Dividendentag
Art
Verhältnis
Dec 24, 2025
Merger
100→1
Oct 17, 2025
Merger
100→1
KeyAI